Drug Shortage Report for AURO-CEFUROXIME
| Report ID | 204518 |
| Drug Identification Number | 02344823 |
| Brand name | AURO-CEFUROXIME |
| Common or Proper name | AURO-CEFUROXIME |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFUROXIME |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 60's |
| ATC code | J01DC |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-09-15 |
| Actual start date | |
| Estimated end date | 2024-01-12 |
| Actual end date | 2024-01-12 |
| Shortage status | Resolved |
| Updated date | 2024-01-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2023-09-15 | English | Compare |